Mast Therapeutics, Inc. in March 2013. Mast Therapeutics, Inc. was founded in 1995 and is headquartered in San Diego, California.. Daily Stock Analysis

Daily Stock Analysis, SWCH, Mast Therapeutics, Inc. in March 2013. Mast Therapeutics, Inc. was founded in 1995 and is headquartered in San Diego, California., priceseries

Mast Therapeutics, Inc. in March 2013. Mast Therapeutics, Inc. was founded in 1995 and is headquartered in San Diego, California.. Daily Stock Analysis
Stock Information
Open
27.28
Close
26.80
High
27.75
Low
26.73
Previous Close
27.43
Daily Price Gain
-0.63
YTD High
28.76
YTD High Date
Jan 3, 2022
YTD Low
23.03
YTD Low Date
Feb 24, 2022
YTD Price Change
-1.35
YTD Gain
-4.80%
52 Week High
29.15
52 Week High Date
Dec 27, 2021
52 Week Low
13.54
52 Week Low Date
Mar 8, 2021
52 Week Price Change
13.22
52 Week Gain
97.32%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Mar 12. 2019
9.04
Apr 9. 2019
10.33
20 Trading Days
14.23%
Link
LONG
May 10. 2019
11.02
May 29. 2019
11.88
12 Trading Days
7.86%
Link
LONG
Aug 7. 2019
13.43
Sep 9. 2019
15.88
22 Trading Days
18.28%
Link
LONG
Mar 24. 2020
12.60
Apr 30. 2020
17.09
26 Trading Days
35.58%
Link
LONG
Jan 26. 2021
16.76
Feb 16. 2021
18.26
14 Trading Days
8.97%
Link
LONG
Mar 31. 2021
16.15
May 3. 2021
18.12
22 Trading Days
12.18%
Link
LONG
Jun 2. 2021
19.31
Jun 23. 2021
21.38
15 Trading Days
10.73%
Link
LONG
Aug 25. 2021
24.12
Sep 20. 2021
25.91
17 Trading Days
7.40%
Link
LONG
Nov 15. 2021
24.87
Dec 1. 2021
26.42
11 Trading Days
6.24%
Link
Company Information
Stock Symbol
SWCH
Exchange
NASDAQ
Company URL
http://www.masttherapeutics.com
Company Phone
512-614-1848
CEO
Brian M. Culley
Headquarters
Texas
Business Address
900 S. CAPITAL OF TEXAS HIGHWAY, SUITE 150, AUSTIN, TX 78746
Sector
Equity
Industry Category
Drugs
Industry Group
Biotechnology
CIK
0001160308
About

Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA.

Description

Mast Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops therapies for serious or life-threatening diseases with significant unmet needs. Its lead product candidate is AIR001, a sodium nitrite solution for inhalation through nebulization, which is in Phase II clinical stage for the treatment of heart failure with preserved ejection fraction, as well as in Phase I/II study in patients with cystic fibrosis. The company was formerly known as ADVENTRX Pharmaceuticals, Inc. and changed its name to Mast Therapeutics, Inc. in March 2013. Mast Therapeutics, Inc. was founded in 1995 and is headquartered in San Diego, California.

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading